Defining the CD59-C9 binding interaction (Q28252317)

1

0 references

Fei Qiao

2

0 references

Starr Hazard

4

0 references

Stephen Tomlinson

Journal of Biological Chemistry

5

0 references

language of work or name

English

0 references

publication date

15 September 2006

0 references

published in

0 references

volume

281

0 references

issue

37

0 references

page(s)

27398-404

0 references

cites work

The role of the complement system in ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Complement therapeutics; history and current progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Use of complement inhibitors in tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Generation of a recombinant, membrane-targeted form of the complement regulator CD59: activity in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Complement function in mAb-mediated cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Mapping the active site of CD59

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Insights into the human CD59 complement binding interface toward engineering new therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Protein flexibility in ligand docking and virtual screening to protein kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

CD59 molecule: a second ligand for CD2 in T cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

Calreticulin Is at the Surface of Circulating Neutrophils and Uses CD59 as an Adaptor Molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603690200

release_omom2pf4ojagfluwcx45yhzn2y

21 January 2018

Identifiers

DOI

10.1074/JBC.M603690200

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/omom2pf4ojagfluwcx45yhzn2y